TherapeuticsMD enters agreements to license products to Mayne Pharma

Dec. 05, 2022 1:46 AM ETTherapeuticsMD, Inc. (TXMD)By: Meghavi Singh, SA News Editor2 Comments
  • TherapeuticsMD (NASDAQ:TXMD) has entered into pact to license its products to an affiliate of Mayne Pharma Group Limited for commercialization in the United States.
  • In addition, TXMD has agreed to sell certain assets to Mayne Pharma to allow Mayne Pharma to commercialize

Recommended For You

Comments (2)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.